Literature DB >> 1572948

Glucose and memory in mild senile dementia of the Alzheimer type.

S Craft1, G Zallen, L D Baker.   

Abstract

Glucose utilization appears to play a role in memory, and patients with Senile Dementia of the Alzheimer Type (SDAT) show particular abnormalities of the glucose system. The present study examined the effects of glucose administration on memory in subjects with mild SDAT and age-matched controls. SDAT subjects demonstrated greater overall increases in blood glucose levels following glucose administration. Normal subjects whose blood glucose levels returned to near baseline following glucose administration showed facilitated memory performance, whereas SDAT subjects whose blood glucose levels remained elevated showed significant improvement following glucose administration. The results suggest that impaired glucose regulation contributes to memory impairment in SDAT.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1572948     DOI: 10.1080/01688639208402827

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  32 in total

Review 1.  The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.

Authors:  G Stennis Watson; Suzanne Craft
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Differential effects of glucose on modulation of emotional and nonemotional spatial memory tasks.

Authors:  A Mohanty; R W Flint
Journal:  Cogn Affect Behav Neurosci       Date:  2001-03       Impact factor: 3.282

3.  The influence on cognition of the interactions between lecithin, carnitine and carbohydrate.

Authors:  David Benton; Rachael T Donohoe
Journal:  Psychopharmacology (Berl)       Date:  2004-02-04       Impact factor: 4.530

Review 4.  Toward a model of memory enhancement in schizophrenia: glucose administration and hippocampal function.

Authors:  William S Stone; Larry J Seidman
Journal:  Schizophr Bull       Date:  2007-05-15       Impact factor: 9.306

5.  Pioglitazone does not increase cerebral glucose utilisation in a murine model of Alzheimer's disease and decreases it in wild-type mice.

Authors:  E Galea; D L Feinstein; P Lacombe
Journal:  Diabetologia       Date:  2006-07-08       Impact factor: 10.122

6.  Association of plasma β-amyloid 40 and 42 concentration with type 2 diabetes among Chinese adults.

Authors:  Xiaobo Peng; Zihui Xu; Xiaoxing Mo; Qianqian Guo; Jiawei Yin; Mengdai Xu; Zhao Peng; Taoping Sun; Li Zhou; Xiaolin Peng; Shufang Xu; Wei Yang; Wei Bao; Zhilei Shan; Xiaoqin Li; Liegang Liu
Journal:  Diabetologia       Date:  2020-02-07       Impact factor: 10.122

Review 7.  The alpha-ketoglutarate-dehydrogenase complex: a mediator between mitochondria and oxidative stress in neurodegeneration.

Authors:  Gary E Gibson; John P Blass; M Flint Beal; Victoria Bunik
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

8.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

Review 9.  Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders.

Authors:  Rasoul Ghasemi; Leila Dargahi; Ali Haeri; Maryam Moosavi; Zahurin Mohamed; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2013-01-20       Impact factor: 5.590

Review 10.  Hypometabolism as a therapeutic target in Alzheimer's disease.

Authors:  Lauren C Costantini; Linda J Barr; Janet L Vogel; Samuel T Henderson
Journal:  BMC Neurosci       Date:  2008-12-03       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.